Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

2.72
Delayed Data
As of Feb 17
 -0.04 / -1.45%
Today’s Change
1.83
Today|||52-Week Range
14.80
+32.68%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close2.76
Today’s open2.70
Day’s range2.68 - 2.80
Volume33,075
Average volume (3 months)112,723
Market cap$9.4M
Dividend yield--
Data as of 4:02pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)-20.00%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.28

Competitors

 Today’s
change
Today’s
% change
BASIBioanalytical System...-0.02-1.79%
YTENYield10 Bioscience I...-0.01-1.39%
HTGMHTG Molecular Diagno...-0.01-0.53%
FSIFlexible Solutions I...-0.02-1.24%
Data as of 3:59pm ET, 02/17/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Secretary
Gary S. Titus
President, Chief Executive Officer &
Director
Anthony J. Gringeri
Corporate headquarters
Calabasas, California

Forecasts


Search for Jobs